These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15832725)

  • 1. [Multiple sclerosis. Danish Society of Multiple Sclerosis Research (DAREMUS)].
    Ravnborg MH
    Ugeskr Laeger; 2005 Mar; 167(12-13):1405. PubMed ID: 15832725
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].
    Sellebjerg FT; Sørensen PS;
    Ugeskr Laeger; 2007 Mar; 169(12):1121. PubMed ID: 17394832
    [No Abstract]   [Full Text] [Related]  

  • 3. New treatment, new hope for those with multiple sclerosis.
    Bren L
    FDA Consum; 2005; 39(2):10-7. PubMed ID: 16121419
    [No Abstract]   [Full Text] [Related]  

  • 4. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
    Oger J; Gibbs E
    Nat Clin Pract Neurol; 2006 Feb; 2(2):76-7. PubMed ID: 16932528
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
    Farrell R; Bendtzen K; Bertolotto A; Clark B; Comabella M; Deisenhammer F; Fogdell-Hahn A; Giovannoni G; Hartung HP; Hemmer B; Hillert J; Kappos L; Killestein J; Lindberg R; Montalban X; Polman C; Sorensen PS;
    J Int Med Res; 2008; 36(1):204-8; author reply 208-10. PubMed ID: 18230281
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.
    Achiron A; Miron S; Shoenfeld Y
    Isr Med Assoc J; 2005 May; 7(5):283-5. PubMed ID: 15909458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the validity of animal models for research into therapies for immune-based disorders.
    't Hart BA; Amor S; Jonker M
    Drug Discov Today; 2004 Jun; 9(12):517-24. PubMed ID: 15183159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta1a treatment for multiple sclerosis.
    Sandberg-Wollheim M
    Expert Rev Neurother; 2005 Jan; 5(1):25-34. PubMed ID: 15853471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ensuring the long-term effectiveness of MS treatment].
    Krankenpfl J; 2005; 43(7-10):235. PubMed ID: 16515305
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon beta-1a].
    Taéron C
    Rev Infirm; 2004 May; (101):39-40. PubMed ID: 15984751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunomodulatory therapy in multiple sclerosis].
    Uitdehaag BM; Jelles B; Killestein J; van Oosten BW; Polman CH
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1435; author reply 1435-6. PubMed ID: 17668612
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic antibodies in multiple sclerosis.
    Goebels N; Becher B
    Neurodegener Dis; 2008; 5(1):5-7. PubMed ID: 18075268
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon causes no myasthenia in a seropositive patient with multiple sclerosis.
    Shimizu H; Kataoka H; Kawahara M; Hirano M; Furiya Y; Ueno S
    Clin Neurol Neurosurg; 2007 Apr; 109(3):277-8. PubMed ID: 17118531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natalizumab and other monoclonal antibodies.
    Ursell MR; O'Connor PW
    Neurol Clin; 2005 Feb; 23(1):233-46, viii. PubMed ID: 15661096
    [No Abstract]   [Full Text] [Related]  

  • 16. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedside to bench: betting on B cells in multiple sclerosis.
    Link H
    Nat Med; 2008 Jun; 14(6):615-6. PubMed ID: 18535578
    [No Abstract]   [Full Text] [Related]  

  • 18. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
    MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-beta1b for multiple sclerosis.
    Burks J
    Expert Rev Neurother; 2005 Mar; 5(2):153-64. PubMed ID: 15853486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic perspectives in multiple sclerosis].
    Lubetzki C
    Rev Prat; 2006 Jun; 56(12):1347-52. PubMed ID: 16948223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.